Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Lore Santoro"'
Autor:
Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, Manuel Bardiès, Lore Santoro, Sophie Gourgou
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Although neuroendocrine tumors (NET) are classed as rare, they have a high prevalence and their incidence is increasing. Effective treatment with lutetium 17-[177Lu]Lu-oxodotreotide (Lutathera®) is possible in patients with well-
Externí odkaz:
https://doaj.org/article/76f37742286647989418218941b0ad25
Autor:
Thierry Galvez, Ikrame Berkane, Simon Thézenas, Marie-Claude Eberlé, Nicolas Flori, Sophie Guillemard, Alina Diana Ilonca, Lore Santoro, Pierre-Olivier Kotzki, Pierre Senesse, Emmanuel Deshayes
Publikováno v:
Nutrients, Vol 15, Iss 13, p 3042 (2023)
18F-FDG PET-CT is routinely performed as part of the initial staging of numerous cancers. Other than having descriptive, predictive and prognostic values for tumors, 18F-FDG PET-CT provides full-body data, which could inform on concurrent pathophysio
Externí odkaz:
https://doaj.org/article/2b9e157c017f45a09078f67da6a8bf05
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1051 (2023)
The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major therapeutic breakthrough in nuclear medicine, particularly since the introduction of 177Lu-radiolabeled somatostatin analogs. These radiopharmaceuticals have especi
Externí odkaz:
https://doaj.org/article/35384b5d6d394af0aad607e3fe005dcc
Autor:
Lore Santoro, L. Pitalot, D. Trauchessec, E. Mora-Ramirez, P. O. Kotzki, M. Bardiès, E. Deshayes
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-17 (2021)
Abstract Background The aim of this study was to compare a commercial dosimetry workstation (PLANET® Dose) and the dosimetry approach (GE Dosimetry Toolkit® and OLINDA/EXM® V1.0) currently used in our department for quantification of the absorbed
Externí odkaz:
https://doaj.org/article/5aecc2ed87134d089168f16df155dab0
Autor:
Charlotte Donzé, Léa Rubira, Lore Santoro, Pierre Olivier Kotzki, Emmanuel Deshayes, Cyril Fersing
Publikováno v:
Healthcare, Vol 10, Iss 11, p 2247 (2022)
Securing both the patient and radiopharmaceuticals (RPs) circuit is an essential concern in nuclear medicine (NM). These circuits converge at the RP administration phase, a key step in patient management in NM. In a continuous quality improvement app
Externí odkaz:
https://doaj.org/article/e05a510f81814929a440677d8b5bc65f
Autor:
Lore Santoro, Erick Mora-Ramirez, Dorian Trauchessec, Soufiane Chouaf, Pierre Eustache, Jean-Pierre Pouget, Pierre-Olivier Kotzki, Manuel Bardiès, Emmanuel Deshayes
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-13 (2018)
Abstract Background This study’s aim was to develop our dosimetric methodology using a commercial workstation for the routine evaluation of the organs at risk during peptide receptor radionuclide therapy (PRRT) with 177Lu. Methods First, planar and
Externí odkaz:
https://doaj.org/article/875fb949447f4f1884d589e64bd0029a
Autor:
Carole Allimant, Emmanuel Deshayes, Marilyne Kafrouni, Lore Santoro, Delphine de Verbizier, Marjolaine Fourcade, Christophe Cassinotto, Margaux Hermida, Chloé Guillot, Denis Mariano-Goulart, Boris Guiu
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 931 (2021)
Background: The functional changes that occur over time in the liver following 90Y-radioembolization (RE) using personalized dosimetry (PD) remain to be investigated. Methods: November 2016–October 2019: we retrospectively included hepatocellular c
Externí odkaz:
https://doaj.org/article/0756331d12db48ecae0b0d7bb4ef9720
Autor:
Deshayes, Thierry Galvez, Ikrame Berkane, Simon Thézenas, Marie-Claude Eberlé, Nicolas Flori, Sophie Guillemard, Alina Diana Ilonca, Lore Santoro, Pierre-Olivier Kotzki, Pierre Senesse, Emmanuel
Publikováno v:
Nutrients; Volume 15; Issue 13; Pages: 3042
18F-FDG PET-CT is routinely performed as part of the initial staging of numerous cancers. Other than having descriptive, predictive and prognostic values for tumors, 18F-FDG PET-CT provides full-body data, which could inform on concurrent pathophysio
Autor:
Anissa Barakat, Lore Santoro, Myrtille Vivien, Pierre-Olivier Kotzki, Emmanuel Deshayes, Sonia Khier
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics.
Autor:
Jean-Pierre Pouget, Lore Santoro, Bérengère Piron, Salomé Paillas, Riad Ladjohounlou, Alexandre Pichard, Sophie Poty, Emmanuel Deshayes, Julie Constanzo, Manuel Bardiès
Publikováno v:
Nuclear Medicine and Biology. :53-64
Targeted radionuclide therapy (TRT) is used to treat disseminated or metastatic tumours in which conventional external beam radiotherapy (EBRT) would have unacceptable side effects. Unlike EBRT, TRT delivers low doses at a continuous low dose rate. I